CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy
Clinical trial NCT00658437 · COMPLETED
Trial details
- NCT number
- NCT00658437
- Sponsor
- Cytavis Biopharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-08-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.